{
    "paper_id": "PMC7173451",
    "metadata": {
        "title": "Special studies",
        "authors": [
            {
                "first": "Susan",
                "middle": [
                    "C"
                ],
                "last": "Lester",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Almost all histochemical stains are suitable for use on formalin-fixed tissues. Common stains and their uses are listed in Table 7-1\n. However, numerous other types of stains and modifications are used and pathologists must be aware of individual laboratory practices.",
            "cite_spans": [],
            "section": "HISTOCHEMISTRY",
            "ref_spans": [
                {
                    "start": 123,
                    "end": 132,
                    "mention": "Table 7-1",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "\nThe WebPath section of the University of Utah site (http://medlib.med.utah.edu) has useful descriptions of special stains and illustrative photographs.",
            "cite_spans": [],
            "section": "HISTOCHEMISTRY",
            "ref_spans": []
        },
        {
            "text": "A differential diagnosis is generated after examination of the H&E stained slides. Immunohistochemistry is then used to gain evidence for or against diagnostic possibilities. \u201cTrolling\u201d cases through an immunohistochemistry laboratory by ordering numerous antibody studies without a clear reason in mind is more likely to lead to misguided diagnosis due to aberrant immunoreactivity than to provide an unexpected correct diagnosis.",
            "cite_spans": [],
            "section": "Use of immunohistochemistry ::: Use of immunohistochemistry ::: Use of immunohistochemistry ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": []
        },
        {
            "text": "A very useful website has been developed by Dr. Dennis M. Frisman (http://www.immunoquery.com): it tabulates published literature on the immunoreactivity profiles for numerous tumors. There is also a comprehensive list of the included references with web links.",
            "cite_spans": [],
            "section": "Use of immunohistochemistry ::: Use of immunohistochemistry ::: Use of immunohistochemistry ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": []
        },
        {
            "text": "There are no absolute rules for immunoreactivity in cells and tissues. Aberrant positive immunoreactivity (or absence of immunoreactivity) is occasionally observed for all antibodies, either due to biologic variability (e.g., occasional keratin-positive melanomas) or technical factors (impure antibodies, cross-reaction with other antigens, failure to preserve antigenicity). Thus, immunohistochemical markers are used most effectively as panels of markers, with interpretation based on an immunohistochemical profile.",
            "cite_spans": [],
            "section": "Panels ::: Use of immunohistochemistry ::: Use of immunohistochemistry ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": []
        },
        {
            "text": "Tissue is often dislodged from normal glass slides during the treatments required for IHC. Slides must be coated (e.g., with glue, poly-l-lysine, gelatin, albumin) or special commercial slides must be used. If slides are being prepared by another laboratory, the type of glass slide to be used must be specified.",
            "cite_spans": [],
            "section": "Slides for immunohistochemistry ::: Use of immunohistochemistry ::: Use of immunohistochemistry ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": []
        },
        {
            "text": "Some fixatives destroy some antigens (e.g., Bouin's diminishes ER immunoreactivity, keratins are not well preserved in B5).1 Most studies are based on formalin-fixed tissue. Results cannot be assumed to be equivalent for other fixatives.",
            "cite_spans": [
                {
                    "start": 123,
                    "end": 124,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                }
            ],
            "section": "Type of fixative. ::: Type of fixative. ::: Factors affecting immunogenicity ::: Use of immunohistochemistry ::: Use of immunohistochemistry ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": []
        },
        {
            "text": "Protein cross-linking and antigenicity generally decrease with fixation times over 24 hours. To some extent, this effect can be reversed using antigen-retrieval methods.",
            "cite_spans": [],
            "section": "Length of time of fixation in formalin. ::: Type of fixative. ::: Factors affecting immunogenicity ::: Use of immunohistochemistry ::: Use of immunohistochemistry ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": []
        },
        {
            "text": "This decreases the antigenicity of some epitopes (predominantly nuclear) but not others (predominantly cytoplasmic).2 Decalcifying agents using EDTA do not alter immunogenicity.",
            "cite_spans": [
                {
                    "start": 116,
                    "end": 117,
                    "mention": "2",
                    "ref_id": "BIBREF9"
                }
            ],
            "section": "Prior decalcification in hydrochloric acid. ::: Type of fixative. ::: Factors affecting immunogenicity ::: Use of immunohistochemistry ::: Use of immunohistochemistry ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": []
        },
        {
            "text": "Decreased: ER, PR, Ki-67, p53, Ber-EP4 (tumor cells).",
            "cite_spans": [],
            "section": "Prior decalcification in hydrochloric acid. ::: Type of fixative. ::: Factors affecting immunogenicity ::: Use of immunohistochemistry ::: Use of immunohistochemistry ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": []
        },
        {
            "text": "Not affected: calcitonin, chromogranin, GCDFP-15, HMB-45, thyroglobulin, S100, PSA, keratins (CK 20, CAM 5.2, AE1/AE3), others.",
            "cite_spans": [],
            "section": "Prior decalcification in hydrochloric acid. ::: Type of fixative. ::: Factors affecting immunogenicity ::: Use of immunohistochemistry ::: Use of immunohistochemistry ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": []
        },
        {
            "text": "The immunoreactivity of the majority of antigens declines over days to weeks and may be lost completely at 1 month.3, 4, 5, 6 The loss may be due to oxidation of amino acids with exposure of tissue to air, as the immunogenicity of tissue deeper in the block can be preserved for many years. Antigen-retrieval methods do not completely restore the antigenicity of old slides. Coating slides with paraffin, storing the slides in a nitrogen desiccator, and/or storing at lower temperatures can partially preserve antigenicity. However, studies should be performed on newly cut slides, if possible.",
            "cite_spans": [
                {
                    "start": 115,
                    "end": 116,
                    "mention": "3",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 118,
                    "end": 119,
                    "mention": "4",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 121,
                    "end": 122,
                    "mention": "5",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 124,
                    "end": 125,
                    "mention": "6",
                    "ref_id": "BIBREF13"
                }
            ],
            "section": "Length of time since the glass slide was cut.3bib3bibr, 4bib4bibr, 5bib5bibr, 6bib6bibr ::: Factors affecting immunogenicity ::: Use of immunohistochemistry ::: Use of immunohistochemistry ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": []
        },
        {
            "text": "These include proteolysis, heating (microwave, steam), and special incubation fluids. To some extent these methods reverse the effects of formalin fixation. Variable effects are observed for different antibodies.",
            "cite_spans": [],
            "section": "Antigen-retrieval procedures. ::: Factors affecting immunogenicity ::: Use of immunohistochemistry ::: Use of immunohistochemistry ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": []
        },
        {
            "text": " ",
            "cite_spans": [],
            "section": "Incubation time, incubation temperature, dilution of antibody. ::: Type of antibody (polyclonal versus monoclonal versus mixture of different monoclonals), epitope detected. ::: Factors affecting immunogenicity ::: Use of immunohistochemistry ::: Use of immunohistochemistry ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": []
        },
        {
            "text": " ",
            "cite_spans": [],
            "section": "Methods of signal amplification. ::: Type of antibody (polyclonal versus monoclonal versus mixture of different monoclonals), epitope detected. ::: Factors affecting immunogenicity ::: Use of immunohistochemistry ::: Use of immunohistochemistry ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": []
        },
        {
            "text": " ",
            "cite_spans": [],
            "section": "Temperature of baking the slide. ::: Type of antibody (polyclonal versus monoclonal versus mixture of different monoclonals), epitope detected. ::: Factors affecting immunogenicity ::: Use of immunohistochemistry ::: Use of immunohistochemistry ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": []
        },
        {
            "text": "Tissues known to be immunoreactive should be included each time an antibody is used for a test case. Internal positive controls should always be evaluated when present as they control not only for the technique used but also for the antigenicity of the tissue under investigation. Table 7-30\n(see pp. 103) lists normal cells that are generally immunoreactive for each antibody. Some laboratories have used vimentin as a control for immunogenicity as almost all tissue should demonstrate positivity.7 Given the wide and nonspecific distribution of vimentin, smooth muscle \u03b1-actin may be more useful in this context as pericytes, vascular smooth muscle, and myoepithelial cells present in most tissues are immunoreactive.",
            "cite_spans": [
                {
                    "start": 498,
                    "end": 499,
                    "mention": "7",
                    "ref_id": "BIBREF14"
                }
            ],
            "section": "Positive controls. ::: Controls ::: Use of immunohistochemistry ::: Use of immunohistochemistry ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": [
                {
                    "start": 281,
                    "end": 291,
                    "mention": "Table 7-30",
                    "ref_id": "TABREF23"
                }
            ]
        },
        {
            "text": "Examples of internal controls are:\u2022S100: Normal nerves, melanocytes and Langerhans' cells in epidermis, cartilage, some myoepithelial cells, skin adnexa\u2022Estrogen and progesterone receptors: Normal luminal cells in ducts and lobules of the breast\u2022CD31, FVIII: Vascular endothelium\u2022c-kit: Mast cells\u2022Smooth muscle \u03b1-actin: Blood vessel walls, myoepithelial cells in the breast\u2022Vimentin: Blood vessels, stromal cells\u2022High-molecular-weight keratin: Squamous epithelium\u2022Low-molecular-weight keratin: Glandular epithelium\u2022CD15: polymorphonuclear leukocytes.\n",
            "cite_spans": [],
            "section": "Positive controls. ::: Controls ::: Use of immunohistochemistry ::: Use of immunohistochemistry ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": []
        },
        {
            "text": "The primary antibody is replaced with non-immune animal serum diluted to the same concentration as the primary antibody for a negative control. No positive reaction should be present. If multiple primary antibodies that are reactive with different target antigens are used, then they may serve as negative controls for each other. Although the best negative control would be to use antibody preabsorbed against the target antigen, this is rarely practical in a diagnostic laboratory. Diagnostic slides should also be evaluated for internal negative controls. Aberrant immunoreactivity of tissues that should not be immunoreactive indicates that the immunoreactivity is nonspecific and should not be used for interpretation.",
            "cite_spans": [],
            "section": "Negative controls. ::: Controls ::: Use of immunohistochemistry ::: Use of immunohistochemistry ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": []
        },
        {
            "text": "Immunoreactivity of tumor cells must be distinguished from immunoreactivity of normal entrapped cells (e.g., desmin-positive skeletal muscle cells infiltrated by tumor, S100-positive Langerhans' cells in tumors, smooth muscle \u03b1-actin-positive blood vessels, etc.). Plasma cells have large amounts of cytoplasmic immunoglobulin and can react nonspecifically with many antibodies.",
            "cite_spans": [],
            "section": "Identification of immunoreactive cells. ::: Identification of immunoreactive cells. ::: Identification of immunoreactive cells. ::: Evaluation of immunoperoxidase studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": []
        },
        {
            "text": "Some weak immunoreactivity may be present as a nonspecific finding. It is important to compare positive cells with control slides and with normally non-immunoreactive cells to determine whether the immunoreactivity is significant.",
            "cite_spans": [],
            "section": "Intensity of immunoreactivity. ::: Identification of immunoreactive cells. ::: Identification of immunoreactive cells. ::: Evaluation of immunoperoxidase studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": []
        },
        {
            "text": "In some cases, the number of positive cells may be important as a criterion for positivity or as a prognostic marker (e.g., markers of proliferation such as Ki-67). In other cases, rare weakly positive cells must be distinguished from intermingled normal cells or just nonspecific immunoreactivity.",
            "cite_spans": [],
            "section": "Number of immunoreactive cells. ::: Identification of immunoreactive cells. ::: Identification of immunoreactive cells. ::: Evaluation of immunoperoxidase studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": []
        },
        {
            "text": "Specific criteria for evaluating IHC have been developed for a few antibodies (see Tables 15-3, 15-4, and 7-28\n). However, criteria do not exist for most antibodies or are not universally used by all pathologists. The significance of immunoreactivity varies with the type of lesion, the antibody, and the specific assay. Strong positivity in the majority of cells is easily interpreted as a positive result. As the number of positive cells decreases, and the intensity of immunoreactivity weakens, the lower threshold of a \u201cpositive\u201d result becomes more difficult to determine.",
            "cite_spans": [],
            "section": "Criteria for a \u201cpositive\u201d result. ::: Identification of immunoreactive cells. ::: Identification of immunoreactive cells. ::: Evaluation of immunoperoxidase studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": [
                {
                    "start": 106,
                    "end": 110,
                    "mention": "7-28",
                    "ref_id": "TABREF20"
                }
            ]
        },
        {
            "text": "Alkaline phosphatase chromogens (red color) fade over time. DAB (brown color) is more permanent. This is not a problem in evaluating current pathology specimens. However, if immunoperoxidase slides are reviewed after a period of time, some chromogens may have faded and once-positive results may appear to be negative.",
            "cite_spans": [],
            "section": "Time. ::: Identification of immunoreactive cells. ::: Identification of immunoreactive cells. ::: Evaluation of immunoperoxidase studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": []
        },
        {
            "text": "Location of immunoreactivity (Fig. 7-1\n). Antigens are present in specific sites. Some antigens may be present in more than one location or be extracellular.",
            "cite_spans": [],
            "section": "Time. ::: Identification of immunoreactive cells. ::: Identification of immunoreactive cells. ::: Evaluation of immunoperoxidase studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": [
                {
                    "start": 30,
                    "end": 38,
                    "mention": "Fig. 7-1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "\nArtifacts. Nonspecific positivity should be suspected when immunoreactivity is present in atypical locations:",
            "cite_spans": [],
            "section": "Time. ::: Identification of immunoreactive cells. ::: Identification of immunoreactive cells. ::: Evaluation of immunoperoxidase studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": []
        },
        {
            "text": "\nBackground: Suspect nonspecific positivity if normal cells or stroma are positive. This can occur with suboptimal performance of the assay or suboptimal antibodies.",
            "cite_spans": [],
            "section": "Time. ::: Identification of immunoreactive cells. ::: Identification of immunoreactive cells. ::: Evaluation of immunoperoxidase studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": []
        },
        {
            "text": "\nEdge artifact: Antibodies can pool at edges or in holes in tissue. True positivity should also be present in the center of the tissue.",
            "cite_spans": [],
            "section": "Time. ::: Identification of immunoreactive cells. ::: Identification of immunoreactive cells. ::: Evaluation of immunoperoxidase studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": []
        },
        {
            "text": "\nNecrosis or crushing of cells: Nonspecific positivity can be seen in disrupted cells. Although keratin is generally reliable in necrotic tumors, other markers generally should not be interpreted.",
            "cite_spans": [],
            "section": "Time. ::: Identification of immunoreactive cells. ::: Identification of immunoreactive cells. ::: Evaluation of immunoperoxidase studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": []
        },
        {
            "text": "\nInappropriate location (e.g., cytoplasm instead of nucleus): Occasionally ER or PR is present in the cytoplasm instead of the nucleus. This is not interpreted as a positive result.",
            "cite_spans": [],
            "section": "Time. ::: Identification of immunoreactive cells. ::: Identification of immunoreactive cells. ::: Evaluation of immunoperoxidase studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": []
        },
        {
            "text": "The combination of these two cytokeratins has been found to be useful to divide carcinomas into four main groups (Ck7+/Ck20+, Ck7+/Ck20\u2013, Ck7\u2013/Ck20+, Ck7\u2013/Ck20\u2013).8, 9, 10\n",
            "cite_spans": [
                {
                    "start": 162,
                    "end": 163,
                    "mention": "8",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 165,
                    "end": 166,
                    "mention": "9",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 168,
                    "end": 170,
                    "mention": "10",
                    "ref_id": "BIBREF1"
                }
            ],
            "section": "Cytokeratin 7 and Cytokeratin ::: Common panels for immunohistochemical studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": []
        },
        {
            "text": "In Table 7-3, Table 7-4, Table 7-5, Table 7-6, Table 7-7, other commonly used antibodies have been included to show differences within each group. The most useful additional antibodies depend on the specific differential diagnosis.",
            "cite_spans": [],
            "section": "Cytokeratin 7 and Cytokeratin ::: Common panels for immunohistochemical studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": [
                {
                    "start": 3,
                    "end": 12,
                    "mention": "Table 7-3",
                    "ref_id": "TABREF22"
                },
                {
                    "start": 14,
                    "end": 23,
                    "mention": "Table 7-4",
                    "ref_id": "TABREF32"
                },
                {
                    "start": 25,
                    "end": 34,
                    "mention": "Table 7-5",
                    "ref_id": "TABREF33"
                },
                {
                    "start": 36,
                    "end": 45,
                    "mention": "Table 7-6",
                    "ref_id": "TABREF34"
                },
                {
                    "start": 47,
                    "end": 56,
                    "mention": "Table 7-7",
                    "ref_id": "TABREF35"
                }
            ]
        },
        {
            "text": "See Table 7-8.",
            "cite_spans": [],
            "section": "Spindle cell lesions, soft tissue lesions, and sarcomas ::: Common panels for immunohistochemical studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": [
                {
                    "start": 4,
                    "end": 13,
                    "mention": "Table 7-8",
                    "ref_id": "TABREF36"
                }
            ]
        },
        {
            "text": "See Table 7-9.",
            "cite_spans": [],
            "section": "Small blue cell tumors ::: Common panels for immunohistochemical studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": [
                {
                    "start": 4,
                    "end": 13,
                    "mention": "Table 7-9",
                    "ref_id": "TABREF37"
                }
            ]
        },
        {
            "text": "See Table 7-10.",
            "cite_spans": [],
            "section": "Myoepithelial markers in breast cancer ::: Common panels for immunohistochemical studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": [
                {
                    "start": 4,
                    "end": 14,
                    "mention": "Table 7-10",
                    "ref_id": "TABREF1"
                }
            ]
        },
        {
            "text": "See Table 7-11.",
            "cite_spans": [],
            "section": "Epidermal lesions of the nipple ::: Common panels for immunohistochemical studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": [
                {
                    "start": 4,
                    "end": 14,
                    "mention": "Table 7-11",
                    "ref_id": "TABREF2"
                }
            ]
        },
        {
            "text": "See Table 7-12.",
            "cite_spans": [],
            "section": "Endocervical carcinoma versus endometrial carcinoma ::: Common panels for immunohistochemical studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": [
                {
                    "start": 4,
                    "end": 14,
                    "mention": "Table 7-12",
                    "ref_id": "TABREF3"
                }
            ]
        },
        {
            "text": "See Table 7-13.",
            "cite_spans": [],
            "section": "Endometrial stromal sarcoma versus leiomyosarcoma ::: Common panels for immunohistochemical studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": [
                {
                    "start": 4,
                    "end": 14,
                    "mention": "Table 7-13",
                    "ref_id": "TABREF4"
                }
            ]
        },
        {
            "text": "See Table 7-14.",
            "cite_spans": [],
            "section": "Primary ovarian carcinoma versus metastatic carcinomas ::: Common panels for immunohistochemical studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": [
                {
                    "start": 4,
                    "end": 14,
                    "mention": "Table 7-14",
                    "ref_id": "TABREF5"
                }
            ]
        },
        {
            "text": "See Table 7-15.",
            "cite_spans": [],
            "section": "Ovarian carcinoma versus mesothelioma ::: Common panels for immunohistochemical studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": [
                {
                    "start": 4,
                    "end": 14,
                    "mention": "Table 7-15",
                    "ref_id": "TABREF6"
                }
            ]
        },
        {
            "text": "See Table 7-16.",
            "cite_spans": [],
            "section": "Trophoblastic lesions ::: Common panels for immunohistochemical studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": [
                {
                    "start": 4,
                    "end": 14,
                    "mention": "Table 7-16",
                    "ref_id": "TABREF7"
                }
            ]
        },
        {
            "text": "See Table 7-17.",
            "cite_spans": [],
            "section": "Tumors of germ cells and sex-cord stromal tumors ::: Common panels for immunohistochemical studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": [
                {
                    "start": 4,
                    "end": 14,
                    "mention": "Table 7-17",
                    "ref_id": "TABREF8"
                }
            ]
        },
        {
            "text": "See Table 7-18.",
            "cite_spans": [],
            "section": "Adrenal and kidney tumors ::: Common panels for immunohistochemical studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": [
                {
                    "start": 4,
                    "end": 14,
                    "mention": "Table 7-18",
                    "ref_id": "TABREF9"
                }
            ]
        },
        {
            "text": "See Table-7.19.",
            "cite_spans": [],
            "section": "Tumors of bladder, prostatic, or renal origin ::: Common panels for immunohistochemical studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": [
                {
                    "start": 4,
                    "end": 14,
                    "mention": "Table-7.19",
                    "ref_id": "TABREF10"
                }
            ]
        },
        {
            "text": "See Table 7-20.",
            "cite_spans": [],
            "section": "Prostate carcinoma versus other lesions ::: Common panels for immunohistochemical studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": [
                {
                    "start": 4,
                    "end": 14,
                    "mention": "Table 7-20",
                    "ref_id": "TABREF12"
                }
            ]
        },
        {
            "text": "See Table 7-21.",
            "cite_spans": [],
            "section": "Hepatic tumors ::: Common panels for immunohistochemical studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": [
                {
                    "start": 4,
                    "end": 14,
                    "mention": "Table 7-21",
                    "ref_id": "TABREF13"
                }
            ]
        },
        {
            "text": "See Table 7-22.",
            "cite_spans": [],
            "section": "Thyroid and parathyroid lesions ::: Common panels for immunohistochemical studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": [
                {
                    "start": 4,
                    "end": 14,
                    "mention": "Table 7-22",
                    "ref_id": "TABREF14"
                }
            ]
        },
        {
            "text": "See Table 7-23.",
            "cite_spans": [],
            "section": "B-cell neoplasms ::: Common panels for immunohistochemical studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": [
                {
                    "start": 4,
                    "end": 14,
                    "mention": "Table 7-23",
                    "ref_id": "TABREF15"
                }
            ]
        },
        {
            "text": "See Table 7-24.",
            "cite_spans": [],
            "section": "T-cell neoplasms ::: Common panels for immunohistochemical studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": [
                {
                    "start": 4,
                    "end": 14,
                    "mention": "Table 7-24",
                    "ref_id": "TABREF16"
                }
            ]
        },
        {
            "text": "See Table 7.25.",
            "cite_spans": [],
            "section": "Hodgkin's lymphoma ::: Common panels for immunohistochemical studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": [
                {
                    "start": 4,
                    "end": 14,
                    "mention": "Table 7.25",
                    "ref_id": "TABREF17"
                }
            ]
        },
        {
            "text": "See Table 7-26.",
            "cite_spans": [],
            "section": "Metastatic tumors of unknown origin ::: Common panels for immunohistochemical studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": [
                {
                    "start": 4,
                    "end": 14,
                    "mention": "Table 7-26",
                    "ref_id": "TABREF18"
                }
            ]
        },
        {
            "text": "See Table 7-27.",
            "cite_spans": [],
            "section": "Poorly differentiated tumors ::: Common panels for immunohistochemical studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": [
                {
                    "start": 4,
                    "end": 14,
                    "mention": "Table 7-27",
                    "ref_id": "TABREF19"
                }
            ]
        },
        {
            "text": "See Chapter 15, pages 240\u2013243.",
            "cite_spans": [],
            "section": "Estrogen and progesterone receptor evaluation and HER2/neu score ::: Common panels for immunohistochemical studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": []
        },
        {
            "text": "See Table 7-28.",
            "cite_spans": [],
            "section": "EGFR (HER1) score ::: Common panels for immunohistochemical studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": [
                {
                    "start": 4,
                    "end": 14,
                    "mention": "Table 7-28",
                    "ref_id": "TABREF20"
                }
            ]
        },
        {
            "text": "See Table 7-29.",
            "cite_spans": [],
            "section": "Differential diagnosis of epithelial mesothelioma and lung adenocarcinoma13bib13bibr ::: Common panels for immunohistochemical studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": [
                {
                    "start": 4,
                    "end": 14,
                    "mention": "Table 7-29",
                    "ref_id": "TABREF21"
                }
            ]
        },
        {
            "text": "\nBox 7-1Alternative names for antigens\n\n\n",
            "cite_spans": [],
            "section": "Differential diagnosis of epithelial mesothelioma and lung adenocarcinoma13bib13bibr ::: Common panels for immunohistochemical studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": []
        },
        {
            "text": "The results of immunoperoxidase studies are incorporated into the surgical pathology report.14 The following information is included:\u2022The type of tissue studied: formalin-fixed (or other fixatives) tissue, cryostat sections, cytology preparations, etc.\u2022The type of immunoagents used, being as specific as possible. For example, do not just list \u201ckeratin\u201d but specify the type of keratin (e.g., AE1/AE3).\u2022The results of the studies in sufficient detail to allow interpretation: for example, the type of cell that is immunoreactive (e.g., tumor versus nontumor), intensity of immunoreactivity (e.g. weak, strong), and/or the number of cells immunoreactive (e.g., focal versus diffuse).\u2022Integration of the results into the final diagnosis, specifying whether they confirm or support a diagnosis, make one diagnosis more likely than others, or exclude one or more diagnoses.\n",
            "cite_spans": [
                {
                    "start": 92,
                    "end": 94,
                    "mention": "14",
                    "ref_id": "BIBREF5"
                }
            ],
            "section": "Results ::: Common panels for immunohistochemical studies ::: IMMUNOPEROXIDASE STUDIES",
            "ref_spans": []
        },
        {
            "text": "\n\u2022Diagnostic renal biopsies for glomerular disease\u2022Adenocarcinoma versus mesothelioma (see Table 7-29)\u2022Difficult to classify tumors (Table 7-31\n)\u2022Nerve (e.g., toxic or drug-induced neuropathy) and muscle biopsies (e.g., inclusion body or nemaline myopathy)\u2022Bullous skin diseases (e.g., epidermolysis bullosa)\u2022Ciliary dysmorphology (primary ciliary dyskinesia or Kartagener's syndrome)\u2022Endomyocardial biopsies (e.g., Adriamycin toxicity, amyloid, nemaline)\u2022Liver biopsies for microvesicular fat in acute fatty liver of pregnancy\u2022Small bowel biopsies to look for pathogens (e.g., Whipple's disease)\u2022Congenital, inherited, and metabolic diseases (e.g., ceroid lipofuscinoses)\u2022Prion diseases.\n",
            "cite_spans": [],
            "section": "Indications for EM studies ::: Indications for EM studies ::: ELECTRON MICROSCOPY",
            "ref_spans": [
                {
                    "start": 91,
                    "end": 101,
                    "mention": "Table 7-29",
                    "ref_id": "TABREF21"
                },
                {
                    "start": 133,
                    "end": 143,
                    "mention": "Table 7-31",
                    "ref_id": "TABREF24"
                }
            ]
        },
        {
            "text": "If tissue from a small biopsy is found to be nondiagnostic on H&E, any tissue saved for EM should be retrieved for examination by light microscopy.",
            "cite_spans": [],
            "section": "Note. ::: Note. ::: Method ::: Indications for EM studies ::: ELECTRON MICROSCOPY",
            "ref_spans": []
        },
        {
            "text": "A separate EM report is usually issued. The results should be incorporated into the final diagnosis.",
            "cite_spans": [],
            "section": "Results ::: Indications for EM studies ::: ELECTRON MICROSCOPY",
            "ref_spans": []
        },
        {
            "text": "Frozen tissue is useful for all specimens in which there is a question of a lymphoproliferative disorder, sarcomas, unusual tumors, and muscle biopsies.",
            "cite_spans": [],
            "section": "Indications ::: Indications ::: SNAP-FROZEN TISSUE",
            "ref_spans": []
        },
        {
            "text": "Equipment needed:\u2022Flask\u2022Labeled self-seal bag\u2022Pyrex beaker\u2022Liquid nitrogen\u2022Tin foil\u2022Isopentane (2-methylbutane).\n",
            "cite_spans": [],
            "section": "Protocol for freezing tissue ::: Methods ::: Indications ::: SNAP-FROZEN TISSUE",
            "ref_spans": []
        },
        {
            "text": "\n1.Fill a flask half full with liquid nitrogen. Always wear protective gloves and a face shield. Dry ice can also be used. The liquid nitrogen is kept in a canister in the Reproductive Endocrinology Laboratory. Gloves and a face shield are stored nearby.2.Work in a safety cabinet and wear surgical gloves and goggles. Label a freezer bag with the following:\u2022Date\u2022Patient's name in full\u2022Histology reference number\u2022Diagnosis/type of tissue.\n3.Place 2 cm (\u00be inch) of isopentane (2-methylbutane) into a glass beaker. Lower it gently into the flask containing liquid nitrogen. The isopentane is ready to use when the liquid base is frozen solid (white particles will appear) and the remaining liquid is viscous. Remove the beaker from the flask carefully.4.Using the forceps, drop small pieces of tissue directly into the isopentane. Freeze the tissue for approximately 30 seconds.5.Remove the tissue with the forceps and quickly wrap in aluminum foil. Place the tissue in a labeled freezer bag and place in the flask containing the liquid nitrogen.6.Transfer the specimen bag from the flask to a \u201320\u00b0C freezer.\n\n7.\nDiscard the isopentane in a waste bottle. Liquid nitrogen can be allowed to evaporate.8.Sterilize the beaker and forceps with 10% formalin.9.Dispose of contaminated sharps and specimen containers in appropriate impervious biohazard containers. Wash your hands after removal of gloves.If there is insufficient tissue for snap freezing, a frozen section from the OR Consultation Room may be saved frozen for potential studies. Many cryostats undergo an automatic defrost cycle and tissue left as a block in the cryostat will thaw and refreeze. Thus tissue to be saved frozen should be transferred to a freezer.",
            "cite_spans": [],
            "section": "Technique ::: Methods ::: Indications ::: SNAP-FROZEN TISSUE",
            "ref_spans": []
        },
        {
            "text": "The results of immunoperoxidase studies on frozen tissue are usually incorporated into the surgical pathology report.",
            "cite_spans": [],
            "section": "Results ::: Indications ::: SNAP-FROZEN TISSUE",
            "ref_spans": []
        },
        {
            "text": "Biopsies of some skin diseases (e.g., lupus, pemphigus, pemphigoid, and dermatitis herpetiformis), all diagnostic non-transplant renal biopsies, some transplant renal biopsies, and the evaluation of vasculitis in nerve biopsies.",
            "cite_spans": [],
            "section": "Indications ::: Indications ::: IMMUNOFLUORESCENCE",
            "ref_spans": []
        },
        {
            "text": "Tissue must be submitted fresh.",
            "cite_spans": [],
            "section": "Method ::: Indications ::: IMMUNOFLUORESCENCE",
            "ref_spans": []
        },
        {
            "text": "The results of the examination are usually incorporated into the surgical pathology report.",
            "cite_spans": [],
            "section": "Results ::: Indications ::: IMMUNOFLUORESCENCE",
            "ref_spans": []
        },
        {
            "text": "There is linear or granular staining along the dermal\u2013epidermal junction for multiple immunoreactants (most commonly IgG and less often IgM or C3) in approximately 80% of cases. The specificity increases with the number of positive immunoreactants. Uninvolved sun-exposed skin shows positivity in most patients with active systemic lupus. Uninvolved skin in patients with discoid lupus is usually negative for this test.",
            "cite_spans": [],
            "section": "SLE (lupus band test). ::: SLE (lupus band test). ::: SLE (lupus band test). ::: Immunofluorescence of skin lesions ::: IMMUNOFLUORESCENCE",
            "ref_spans": []
        },
        {
            "text": "Perilesional skin shows linear basement membrane zone C3 and sometimes IgG.",
            "cite_spans": [],
            "section": "Herpes gestationis. ::: SLE (lupus band test). ::: SLE (lupus band test). ::: Immunofluorescence of skin lesions ::: IMMUNOFLUORESCENCE",
            "ref_spans": []
        },
        {
            "text": "Granular IgA is seen at the tips of dermal papillae of uninvolved skin.",
            "cite_spans": [],
            "section": "Dermatitis herpetiformis. ::: SLE (lupus band test). ::: SLE (lupus band test). ::: Immunofluorescence of skin lesions ::: IMMUNOFLUORESCENCE",
            "ref_spans": []
        },
        {
            "text": "IgG and C3 between epidermal cells create a net-like pattern. In pemphigus vulgaris, a split just above the basal cell layer creates a \u201ctombstone\u201d appearance to the row of basal cells at the base of the vesicle. In pemphigus foliaceus and related disorders, the split occurs near the granular cell layer.",
            "cite_spans": [],
            "section": "Pemphigus. ::: SLE (lupus band test). ::: SLE (lupus band test). ::: Immunofluorescence of skin lesions ::: IMMUNOFLUORESCENCE",
            "ref_spans": []
        },
        {
            "text": "Ig and C3 are present along the basement membrane but not between cells. Indirect IF reveals an anti-BM antibody.",
            "cite_spans": [],
            "section": "Pemphigoid. ::: SLE (lupus band test). ::: SLE (lupus band test). ::: Immunofluorescence of skin lesions ::: IMMUNOFLUORESCENCE",
            "ref_spans": []
        },
        {
            "text": "\n\u2022B-cell proliferations: clonal rearrangements of the immunoglobulin heavy and light chain genes; specific translocations (see Table 7-34).\u2022T-cell proliferations: rearrangements of the \u03b3 and \u03b2 T-cell receptor genes.\u2022Leukemias (see Table 7-34).\u2022Post-transplant lymphoproliferative disorders: clonal populations of EBV-infected cells.\u2022Oligodendrogliomas: PCR-based LOH analysis for 1p/19q deletions.\n",
            "cite_spans": [],
            "section": "Indications ::: Indications ::: MOLECULAR GENETIC PATHOLOGY",
            "ref_spans": [
                {
                    "start": 127,
                    "end": 137,
                    "mention": "Table 7-34",
                    "ref_id": "TABREF26"
                },
                {
                    "start": 231,
                    "end": 241,
                    "mention": "Table 7-34",
                    "ref_id": "TABREF26"
                }
            ]
        },
        {
            "text": "Fresh or frozen tissue (e.g., snap-frozen tissue) as well as fluids may be used. Cytologic preparations can be used for FISH.",
            "cite_spans": [],
            "section": "Method of submitting tissue ::: Indications ::: MOLECULAR GENETIC PATHOLOGY",
            "ref_spans": []
        },
        {
            "text": "The results are usually either reported separately or incorporated into the surgical pathology report.",
            "cite_spans": [],
            "section": "Results ::: Indications ::: MOLECULAR GENETIC PATHOLOGY",
            "ref_spans": []
        },
        {
            "text": "Tissue for karyotyping must be fresh, viable, and relatively sterile. However, tissue may be submitted even if it has not been handled under strictly sterile conditions (contamination is not usually a problem). If specimens are to be held overnight, the tissue should be minced (into 1-mm cubes) in a sterile specimen container, covered with culture medium, and held overnight in the refrigerator. Fluids may also be submitted for analysis (especially pleural effusions with a suspicion of mesothelioma).",
            "cite_spans": [],
            "section": "Method for submitting tissue ::: Indications ::: Indications ::: CYTOGENETICS",
            "ref_spans": []
        },
        {
            "text": "The results of the cytogenetic analysis should be incorporated into the final diagnosis.",
            "cite_spans": [],
            "section": "Results ::: Indications ::: CYTOGENETICS",
            "ref_spans": []
        },
        {
            "text": "The following features are suggestive of a hereditary susceptibility to cancer:\u2022Two or more close relatives on the same side of the family with cancer\u2022Evidence of autosomal dominant transmission\u2022Early development of cancer in the patient and relatives (in general, under 50 years of age)\u2022Multiple primary cancers\u2022Multiple types of cancers\u2022Unusual pathologic features of tumors (Table 7-35\n)\u2022A constellation of tumors suggestive of a specific syndrome (Table 7-36\n).Pathologists can aid in the detection of hereditary carcinomas by being aware of the types and pathologic characteristics of carcinomas associated with these syndromes. Patients with germline mutations are important to identify in order to:\u2022Screen patients for other common tumors or other components of the disease\u2022Consider prophylactic surgery or preventive interventions\u2022Offer screening to family members at risk and genetic counseling.Although the sporadic forms of cancers in general far outnumber cases associated with germline mutations, in some cases the appearance or site of a carcinoma is highly suggestive of a known syndrome and further investigation may be warranted.",
            "cite_spans": [],
            "section": "Tumors and diseases associated with germline mutations ::: CYTOGENETICS",
            "ref_spans": [
                {
                    "start": 378,
                    "end": 388,
                    "mention": "Table 7-35",
                    "ref_id": "TABREF27"
                },
                {
                    "start": 452,
                    "end": 462,
                    "mention": "Table 7-36",
                    "ref_id": "TABREF28"
                }
            ]
        },
        {
            "text": "\n\u2022Hydatidiform moles: complete (diploid), partial (triploid).\u2022Some carcinomas: DNA ploidy and S-phase fraction have been reported to be of prognostic significance for some carcinomas (e.g., colon, breast, and prostate) but the analysis is not routinely performed at all institutions or used by all oncologists.\n",
            "cite_spans": [],
            "section": "Indications for ploidy and S-phase analysis ::: Indications for ploidy and S-phase analysis ::: ANALYTICAL CYTOLOGY (FLOW CYTOMETRY)",
            "ref_spans": []
        },
        {
            "text": "\n\u2022Lymphomas.\u2022Leukemias.\n",
            "cite_spans": [],
            "section": "Indications for cell surface marker analysis ::: Indications for ploidy and S-phase analysis ::: ANALYTICAL CYTOLOGY (FLOW CYTOMETRY)",
            "ref_spans": []
        },
        {
            "text": "Single cell suspensions are necessary for analysis. For fresh tissues, cells must be viable. Fresh tissue (approximately 0.3 to 0.5 cm3) is placed in a specimen container and kept moist with HBSS. Tissues can be held overnight in the refrigerator.",
            "cite_spans": [],
            "section": "Method for submitting tissue ::: Indications for ploidy and S-phase analysis ::: ANALYTICAL CYTOLOGY (FLOW CYTOMETRY)",
            "ref_spans": []
        },
        {
            "text": "Formalin-fixed paraffin-embedded sections may also be used for DNA ploidy analysis by the Hedley method, although the results are not as satisfactory due to nuclear fragmentation.",
            "cite_spans": [],
            "section": "Method for submitting tissue ::: Indications for ploidy and S-phase analysis ::: ANALYTICAL CYTOLOGY (FLOW CYTOMETRY)",
            "ref_spans": []
        },
        {
            "text": "The results are usually incorporated into the final surgical pathology report.",
            "cite_spans": [],
            "section": "Results ::: Indications for ploidy and S-phase analysis ::: ANALYTICAL CYTOLOGY (FLOW CYTOMETRY)",
            "ref_spans": []
        },
        {
            "text": "Touch preps or smears are especially valuable for:\u2022Infectious cases (to avoid contamination of the cryostat and aerosolization of infectious agents)\u2022Neuropathology cases, for diagnosis and for the performance of cytogenetic (FISH) analysis\u2022\nTumors (for excellent cytologic detail, especially lymphomas and papillary carcinomas of the thyroid).\n",
            "cite_spans": [],
            "section": "Intraoperative diagnosis. ::: Intraoperative diagnosis. ::: Intraoperative diagnosis. ::: Intraoperative diagnosis. ::: CYTOLOGIC PREPARATIONS FROM SURGICAL SPECIMENS",
            "ref_spans": []
        },
        {
            "text": "Stains for microorganisms can be performed the same day on cytologic smears of specimens from critically ill patients. Do not submit air dried smears of infectious cases for staining as the unfixed material may constitute a hazard to laboratory personnel.",
            "cite_spans": [],
            "section": "Special stains. ::: Intraoperative diagnosis. ::: Intraoperative diagnosis. ::: Intraoperative diagnosis. ::: CYTOLOGIC PREPARATIONS FROM SURGICAL SPECIMENS",
            "ref_spans": []
        },
        {
            "text": "Fat is dissolved during routine processing, but can be demonstrated with fat stains on air dried slides.",
            "cite_spans": [],
            "section": "Special stains. ::: Intraoperative diagnosis. ::: Intraoperative diagnosis. ::: Intraoperative diagnosis. ::: CYTOLOGIC PREPARATIONS FROM SURGICAL SPECIMENS",
            "ref_spans": []
        },
        {
            "text": "Nuclei are intact in touch preparations, unlike tissue sections in which the only partial nuclei are present. This feature makes touch preparations superior for techniques such as FISH and image analysis.",
            "cite_spans": [],
            "section": "Genetic studies (FISH). ::: Intraoperative diagnosis. ::: Intraoperative diagnosis. ::: Intraoperative diagnosis. ::: CYTOLOGIC PREPARATIONS FROM SURGICAL SPECIMENS",
            "ref_spans": []
        },
        {
            "text": "It is always a useful exercise to look at cytology preparations and the corresponding surgical specimen to learn the comparative morphology of these techniques.",
            "cite_spans": [],
            "section": "Genetic studies (FISH). ::: Intraoperative diagnosis. ::: Intraoperative diagnosis. ::: Intraoperative diagnosis. ::: CYTOLOGIC PREPARATIONS FROM SURGICAL SPECIMENS",
            "ref_spans": []
        },
        {
            "text": "\n\u2022Tumors of bone and cartilage.\u2022Tumors invading into bone.\u2022Avascular necrosis.\u2022All bioprosthetic heart valves (to document the degree of calcification).\u2022Breast biopsies or mastectomies performed for mammographic lesions that cannot be located grossly. Paraffin blocks of breast tissue can be radiographed if microcalcifications were seen by specimen radiography but not in histologic sections and were not identified prior to processing.Calcifications can dissolve in formalin over several days. If the demonstration of calcifications is important (e.g., mammographically detected calcifications) it is preferable to process the tissue within 1 to 2 days. If processing is to be delayed, the tissue can be stored in ethanol.",
            "cite_spans": [],
            "section": "Indications ::: Indications ::: SPECIMEN RADIOGRAPHY",
            "ref_spans": []
        },
        {
            "text": "Labeled compounds are sometimes used to localize certain types of tumors (generally neuroendocrine) or sentinel lymph nodes. The patient is injected with the isotope prior to surgery and the surgeon uses a handheld probe to identify the labeled tissue. The amount of radioactivity in the tissue is small; generally it does not pose a hazard to pathologists handling the tissue and does not need special disposal methods. However, each pathology department should consult with the radiation safety department to ensure appropriate handling of such tissues. In some cases, if a gross lesion is not present corresponding to the area of octreotide uptake, specimens can be imaged using a gamma camera.",
            "cite_spans": [],
            "section": "Octreotide and sentinel nodes. ::: Octreotide and sentinel nodes. ::: Method ::: Indications ::: SPECIMEN RADIOGRAPHY",
            "ref_spans": []
        },
        {
            "text": "The radiographs are documented in the gross description and any information gained from the radiograph is incorporated into the surgical pathology report.",
            "cite_spans": [],
            "section": "Results ::: Indications ::: SPECIMEN RADIOGRAPHY",
            "ref_spans": []
        },
        {
            "text": "By request of researchers who have obtained permission from the hospital Human Studies Committee.",
            "cite_spans": [],
            "section": "Indications ::: Indications ::: TISSUE FOR RESEARCH: TUMOR BANK",
            "ref_spans": []
        },
        {
            "text": "Adequate information must be provided by the clinician to allow the pathologist to determine how much of the tissue is needed for diagnostic purposes. Research laboratories should provide containers for the transport of specimens. The name of the laboratory, the type of tissue, and the amount of tissue allocated for research must be carefully documented. Tissue should never be given away if there is any question as to the need for the tissue for diagnostic purposes. In some cases it may be preferable (or possibly required) to withhold the name or other identifiers of the patient for medical confidentiality.",
            "cite_spans": [],
            "section": "Method ::: Indications ::: TISSUE FOR RESEARCH: TUMOR BANK",
            "ref_spans": []
        },
        {
            "text": "\n\u2022Suspected infectious processes.\u2022Suspected sarcoid to exclude an infectious process.\n",
            "cite_spans": [],
            "section": "Indications ::: Indications ::: MICROBIOLOGIC CULTURE AND SMEARS",
            "ref_spans": []
        },
        {
            "text": "The usual request for routine specimens would be:\u2022Bacteria (only includes aerobic culture)\u2022Mycobacteria\u2022Fungal.Other organisms require special culture techniques and must be specifically requested:\u2022Anaerobic bacteria\u2022\nSalmonella, Shigella, and Campylobacter\n\u2022\nNocardia\n\u2022\nNeisseria gonorrhoeae\n\u2022\nBrucella\n\u2022\nLegionella\n\u2022\nFrancisella tularensis\n\u2022\nHelicobacter.\n",
            "cite_spans": [],
            "section": "1. Routine culture. ::: 1. Routine culture. ::: Method ::: Indications ::: MICROBIOLOGIC CULTURE AND SMEARS",
            "ref_spans": []
        },
        {
            "text": "CMV, varicella zoster, adenovirus, and herpes simplex are most commonly requested. Cultures for influenza A and B, Respiratory synctial virus, and parainfluenza require special techniques.",
            "cite_spans": [],
            "section": "2. Viral culture. ::: 1. Routine culture. ::: Method ::: Indications ::: MICROBIOLOGIC CULTURE AND SMEARS",
            "ref_spans": []
        },
        {
            "text": "Usually requires special cultures. Occasionally, mycoplasma can be detected on anaerobic cultures, but this is not the optimal means for identifying this organism.",
            "cite_spans": [],
            "section": "3. Mycoplasma. ::: 1. Routine culture. ::: Method ::: Indications ::: MICROBIOLOGIC CULTURE AND SMEARS",
            "ref_spans": []
        },
        {
            "text": "The results are generally reported by the microbiology laboratory. It is helpful to correlate the results with the pathologic findings, when possible.",
            "cite_spans": [],
            "section": "Results ::: Indications ::: MICROBIOLOGIC CULTURE AND SMEARS",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "TABREF0": {
            "text": "Table 7-1: Histochemical stains\n",
            "type": "table"
        },
        "TABREF1": {
            "text": "Table 7-10: Myoepithelial markers in breast carcinoma\n",
            "type": "table"
        },
        "TABREF2": {
            "text": "Table 7-11: Epidermal lesions of the nipple\n",
            "type": "table"
        },
        "TABREF3": {
            "text": "Table 7-12: Endocervical carcinoma versus endometrial carcinoma\n",
            "type": "table"
        },
        "TABREF4": {
            "text": "Table 7-13: Endometrial stromal sarcoma versus leiomyosarcoma\n",
            "type": "table"
        },
        "TABREF5": {
            "text": "Table 7-14: Primary ovarian carcinoma versus metastatic carcinomas\n",
            "type": "table"
        },
        "TABREF6": {
            "text": "Table 7-15: Ovarian carcinoma versus mesothelioma\n",
            "type": "table"
        },
        "TABREF7": {
            "text": "Table 7-16: Trophoblastic lesions\n",
            "type": "table"
        },
        "TABREF8": {
            "text": "Table 7-17: Tumors of germ cells and sex-cord stromal tumors\n",
            "type": "table"
        },
        "TABREF9": {
            "text": "Table 7-18: Adrenal and kidney tumors\n",
            "type": "table"
        },
        "TABREF10": {
            "text": "Table 7-19: Tumors of bladder, prostatic, or renal origin\n",
            "type": "table"
        },
        "TABREF11": {
            "text": "Table 7-2: Evaluation of positivity of immunohistochemical studies\n",
            "type": "table"
        },
        "TABREF12": {
            "text": "Table 7-20: Prostate carcinoma versus other lesions\n",
            "type": "table"
        },
        "TABREF13": {
            "text": "Table 7-21: Hepatic tumors\n",
            "type": "table"
        },
        "TABREF14": {
            "text": "Table 7-22: Thyroid and parathyroid lesions\n",
            "type": "table"
        },
        "TABREF15": {
            "text": "Table 7-23: B-cell neoplasms\n",
            "type": "table"
        },
        "TABREF16": {
            "text": "Table 7-24: T-cell neoplasms\n",
            "type": "table"
        },
        "TABREF17": {
            "text": "Table 7-25: Hodgkin's lymphoma\n",
            "type": "table"
        },
        "TABREF18": {
            "text": "Table 7-26: Markers for tumors of unknown origin\n",
            "type": "table"
        },
        "TABREF19": {
            "text": "Table 7-27: Markers for poorly differentiated tumors\n",
            "type": "table"
        },
        "TABREF20": {
            "text": "Table 7-28: Scoring of the EGFR (HER 1) test\n",
            "type": "table"
        },
        "TABREF21": {
            "text": "Table 7-29: Differential diagnosis of epithelial mesothelioma and lung adenocarcinoma\n",
            "type": "table"
        },
        "TABREF22": {
            "text": "Table 7-3: Predominantly CK7+/CK20+\n",
            "type": "table"
        },
        "TABREF23": {
            "text": "Table 7-30: Antibodies for immunohistochemistry\n",
            "type": "table"
        },
        "TABREF24": {
            "text": "Table 7-31: Electron microscopic features of poorly differentiated tumors\n",
            "type": "table"
        },
        "TABREF25": {
            "text": "Table 7-33: Common cytogenetic and genetic changes in solid tumors of diagnostic or therapeutic significance\n",
            "type": "table"
        },
        "TABREF26": {
            "text": "Table 7-34: Common cytogenetic changes in lymphomas and leukemias\n",
            "type": "table"
        },
        "TABREF27": {
            "text": "Table 7-35: Pathologic features of tumors and diseases suggestive of a germline mutation\n",
            "type": "table"
        },
        "TABREF28": {
            "text": "Table 7-36: Hereditary syndromes associated with multiple tumors\n",
            "type": "table"
        },
        "TABREF29": {
            "text": "Table 7-37: Identification of infectious diseases\n",
            "type": "table"
        },
        "TABREF31": {
            "text": "Table 7-32: Cells, tumors, and structures with characteristic findings by electron microscopy\n",
            "type": "table"
        },
        "TABREF32": {
            "text": "Table 7-4: CK7\u2212/CK20+\n",
            "type": "table"
        },
        "TABREF33": {
            "text": "Table 7-5: Predominantly CK7+/CK20\u2212\n",
            "type": "table"
        },
        "TABREF34": {
            "text": "Table 7-6: Predominantly CK7\u2212/CK20\u2212\n",
            "type": "table"
        },
        "TABREF35": {
            "text": "Table 7-7: No dominant CK7/CK20 pattern or pattern unknown\n",
            "type": "table"
        },
        "TABREF36": {
            "text": "Table 7-8: Spindle-cell/soft-tissue lesions and sarcomas\n",
            "type": "table"
        },
        "TABREF37": {
            "text": "Table 7-9: Small blue cell tumors\n",
            "type": "table"
        },
        "FIGREF0": {
            "text": "Figure 7-1: Location of immunoreactivity.",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Effect of formalin fixation and processing on immunohistochemistry",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Werner",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Chott",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Fabiano",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Battifora",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Am J Surg Pathol",
            "volume": "24",
            "issn": "",
            "pages": "1016-1019",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas",
            "authors": [
                {
                    "first": "NP",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Zee",
                    "suffix": ""
                },
                {
                    "first": "RJ",
                    "middle": [],
                    "last": "Zarbo",
                    "suffix": ""
                },
                {
                    "first": "CE",
                    "middle": [],
                    "last": "Bacchi",
                    "suffix": ""
                },
                {
                    "first": "AM",
                    "middle": [],
                    "last": "Gown",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "Appl Immunohistochem",
            "volume": "3",
            "issn": "",
            "pages": "99-107",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Appraisal of the comparative utility of immunohistochemistry and electron microscopy in the diagnosis of childhood round cell tumors",
            "authors": [
                {
                    "first": "GW",
                    "middle": [],
                    "last": "Mierau",
                    "suffix": ""
                },
                {
                    "first": "PJ",
                    "middle": [],
                    "last": "Berry",
                    "suffix": ""
                },
                {
                    "first": "RL",
                    "middle": [],
                    "last": "Malott",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "Ultrastruct Pathol",
            "volume": "20",
            "issn": "",
            "pages": "507-517",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "Diagnostic strategies for unknown primary cancer",
            "authors": [
                {
                    "first": "GR",
                    "middle": [],
                    "last": "Varadhachary",
                    "suffix": ""
                },
                {
                    "first": "JL",
                    "middle": [],
                    "last": "Abbruzzese",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Lenzi",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Cancer",
            "volume": "100",
            "issn": "",
            "pages": "1776-1785",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "Pathology of mesothelioma",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Corson",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Thorac Surg Clin",
            "volume": "14",
            "issn": "",
            "pages": "447-460",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "Incorporation of immunostaining data in anatomic pathology reports",
            "authors": [
                {
                    "first": "PM",
                    "middle": [],
                    "last": "Banks",
                    "suffix": ""
                }
            ],
            "year": 1992,
            "venue": "Am J Surg Pathol",
            "volume": "16",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "Mucin antibodies \u2013 new tools in diagnosis and therapy of cancer",
            "authors": [
                {
                    "first": "VA",
                    "middle": [],
                    "last": "Wittel",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Goel",
                    "suffix": ""
                },
                {
                    "first": "GC",
                    "middle": [],
                    "last": "Varshney",
                    "suffix": ""
                },
                {
                    "first": "SK",
                    "middle": [],
                    "last": "Batra",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Front Biosci",
            "volume": "6",
            "issn": "D",
            "pages": "1296-1310",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2",
            "authors": [
                {
                    "first": "SR",
                    "middle": [],
                    "last": "Lakhani",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "J Clin Oncol",
            "volume": "20",
            "issn": "",
            "pages": "2310-2318",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "Effect of decalcification and fixation in paraffin-section immunohistochemistry",
            "authors": [
                {
                    "first": "JM",
                    "middle": [],
                    "last": "Arber",
                    "suffix": ""
                },
                {
                    "first": "DA",
                    "middle": [],
                    "last": "Arber",
                    "suffix": ""
                },
                {
                    "first": "KA",
                    "middle": [],
                    "last": "Jenkins",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Battifora",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "Appl Immunohistochem",
            "volume": "4",
            "issn": "",
            "pages": "241-248",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF10": {
            "title": "Long-term preservation of antigenicity on tissue microarrays",
            "authors": [
                {
                    "first": "KA",
                    "middle": [],
                    "last": "DiVito",
                    "suffix": ""
                },
                {
                    "first": "LA",
                    "middle": [],
                    "last": "Charette",
                    "suffix": ""
                },
                {
                    "first": "DL",
                    "middle": [],
                    "last": "Rimm",
                    "suffix": ""
                },
                {
                    "first": "RL",
                    "middle": [],
                    "last": "Camp",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Lab Invest",
            "volume": "84",
            "issn": "",
            "pages": "1071-1078",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF11": {
            "title": "Loss of tumor marker immunostaining intensity on stored paraffin slides of breast cancer",
            "authors": [
                {
                    "first": "TW",
                    "middle": [],
                    "last": "Jacobs",
                    "suffix": ""
                },
                {
                    "first": "JE",
                    "middle": [],
                    "last": "Prioleau",
                    "suffix": ""
                },
                {
                    "first": "IE",
                    "middle": [],
                    "last": "Stillman",
                    "suffix": ""
                },
                {
                    "first": "SJ",
                    "middle": [],
                    "last": "Schnitt",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "J Natl Cancer Inst",
            "volume": "88",
            "issn": "",
            "pages": "1054-1059",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF12": {
            "title": "Variability of immunohistochemical reactivity on paraffin slides",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Bertheau",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Cazals-Hatem",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Meignin",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "J Clin Pathol",
            "volume": "51",
            "issn": "",
            "pages": "370-374",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF13": {
            "title": "Assessment of problems in diagnostic and research immunohistochemistry associated with epitope instability in stored paraffin sections",
            "authors": [
                {
                    "first": "LJ",
                    "middle": [],
                    "last": "van den Broek",
                    "suffix": ""
                },
                {
                    "first": "MJ",
                    "middle": [],
                    "last": "van de Vijver",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Appl Immunohistochem Mol Morphol",
            "volume": "8",
            "issn": "",
            "pages": "316-321",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF14": {
            "title": "Assessment of antigen damage in immunohistochemistry, the vimentin internal control",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Battifora",
                    "suffix": ""
                }
            ],
            "year": 1991,
            "venue": "Am J Clin Pathol",
            "volume": "6",
            "issn": "",
            "pages": "669-671",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF15": {
            "title": "Keratin expression in human tissues and neoplasms",
            "authors": [
                {
                    "first": "PG",
                    "middle": [],
                    "last": "Chu",
                    "suffix": ""
                },
                {
                    "first": "LM",
                    "middle": [],
                    "last": "Weiss",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Histopathology",
            "volume": "40",
            "issn": "",
            "pages": "403-439",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF16": {
            "title": "Cytokeratin 7 and 20 expression in choroid plexus tumors: utility in differentiating these neoplasms from metastatic carcinomas",
            "authors": [
                {
                    "first": "KA",
                    "middle": [],
                    "last": "Gyure",
                    "suffix": ""
                },
                {
                    "first": "AC",
                    "middle": [],
                    "last": "Morrison",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Mod Pathol",
            "volume": "13",
            "issn": "",
            "pages": "638-643",
            "other_ids": {
                "DOI": []
            }
        }
    }
}